Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:orlistat
|
| gptkbp:approvedBy |
gptkb:FDA
2007 |
| gptkbp:availableOn |
over-the-counter medication
|
| gptkbp:brand |
Orlistat
|
| gptkbp:contraindication |
pregnancy
cholestasis chronic malabsorption syndrome |
| gptkbp:form |
capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Alli
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:marketedIn |
gptkb:European_Union
gptkb:United_Kingdom gptkb:United_States |
| gptkbp:mechanismOfAction |
lipase inhibitor
|
| gptkbp:notRecommendedFor |
children under 18 years
|
| gptkbp:powers |
60 mg
|
| gptkbp:prescriptionStatus |
over-the-counter
|
| gptkbp:requiresDiet |
low-fat diet
|
| gptkbp:sideEffect |
flatulence
oily spotting frequent bowel movements |
| gptkbp:storage |
room temperature
|
| gptkbp:usedFor |
weight loss
|
| gptkbp:bfsParent |
gptkb:Alli_Paasikivi
|
| gptkbp:bfsLayer |
6
|